Cited In for PMID: 22493093

Year	Number of Results
2012	3
2013	10
2014	17
2015	12
2016	19
2017	15
2018	18
2019	24
2020	29
2021	23
2022	20
2023	27
2024	7

1

Elevated TCA cycle function in the pathology of diet-induced hepatic insulin resistance and fatty liver.

Satapati S, Sunny NE, Kucejova B, Fu X, He TT, Méndez-Lucas A, Shelton JM, Perales JC, Browning JD, Burgess SC. Satapati S, et al. J Lipid Res. 2012 Jun;53(6):1080-92. doi: 10.1194/jlr.M023382. Epub 2012 Apr 9. J Lipid Res. 2012. PMID: 22493093 Free PMC article.

2

VCD-induced menopause mouse model reveals reprogramming of hepatic metabolism.

Kumari R, Ponte ME, Franczak E, Prom JC, O'Neil MF, Sardiu ME, Lutkewitte AJ, Christenson LK, Shankar K, Morris EM, Thyfault JP. Kumari R, et al. Mol Metab. 2024 Apr;82:101908. doi: 10.1016/j.molmet.2024.101908. Epub 2024 Mar 1. Mol Metab. 2024. PMID: 38432400 Free PMC article.

3

The therapeutic mechanisms and beneficial effects of ursodeoxycholic acid in the treatment of nonalcoholic fatty liver disease: a systematic review.

Stan SI, Biciuşcă V, Clenciu D, Mitrea A, Boldeanu MV, Durand P, Dănoiu S. Stan SI, et al. Med Pharm Rep. 2024 Jan;97(1):12-25. doi: 10.15386/mpr-2629. Epub 2024 Jan 29. Med Pharm Rep. 2024. PMID: 38344336 Free PMC article. Review.

4

Hepatic glucose metabolism in the steatotic liver.

Scoditti E, Sabatini S, Carli F, Gastaldelli A. Scoditti E, et al. Nat Rev Gastroenterol Hepatol. 2024 Feb 2. doi: 10.1038/s41575-023-00888-8. Online ahead of print. Nat Rev Gastroenterol Hepatol. 2024. PMID: 38308003 Review.

5

Targeting the Metabolic Paradigms in Cancer and Diabetes.

Bosso M, Haddad D, Al Madhoun A, Al-Mulla F. Bosso M, et al. Biomedicines. 2024 Jan 17;12(1):211. doi: 10.3390/biomedicines12010211. Biomedicines. 2024. PMID: 38255314 Free PMC article. Review.

6

Metformin: update on mechanisms of action on liver diseases.

Ruan G, Wu F, Shi D, Sun H, Wang F, Xu C. Ruan G, et al. Front Nutr. 2023 Dec 14;10:1327814. doi: 10.3389/fnut.2023.1327814. eCollection 2023. Front Nutr. 2023. PMID: 38192642 Free PMC article. Review.

7

Comparison of HepaRG and HepG2 cell lines to model mitochondrial respiratory adaptations in non‑alcoholic fatty liver disease.

Maseko TE, Elkalaf M, Peterová E, Lotková H, Staňková P, Melek J, Dušek J, Žádníková P, Čížková D, Bezrouk A, Pávek P, Červinková Z, Kučera O. Maseko TE, et al. Int J Mol Med. 2024 Feb;53(2):18. doi: 10.3892/ijmm.2023.5342. Epub 2024 Jan 8. Int J Mol Med. 2024. PMID: 38186319 Free PMC article.

8

NME4 mediates metabolic reprogramming and promotes nonalcoholic fatty liver disease progression.

Xie S, Yuan L, Sui Y, Feng S, Li H, Li X. Xie S, et al. EMBO Rep. 2024 Jan;25(1):378-403. doi: 10.1038/s44319-023-00012-6. Epub 2023 Dec 14. EMBO Rep. 2024. PMID: 38177901 Free PMC article.

9

Thyroid Hormone and Mitochondrial Dysfunction: Therapeutic Implications for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Ramanathan R, Patwa SA, Ali AH, Ibdah JA. Ramanathan R, et al. Cells. 2023 Dec 9;12(24):2806. doi: 10.3390/cells12242806. Cells. 2023. PMID: 38132126 Free PMC article. Review.

10

Unraveling the complex connection between ketone bodies and insulin resistance.

Puchalska P. Puchalska P. Acta Physiol (Oxf). 2024 Feb;240(2):e14077. doi: 10.1111/apha.14077. Epub 2023 Dec 22. Acta Physiol (Oxf). 2024. PMID: 38131693 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

205 results

Results by year